[Molecular link between inefficient GluA2 RNA editing and TDP-43 pathology in ALS motor neurons].
The motor neurons of sporadic amyotrophic lateral sclerosis (ALS) patients exhibit several molecular abnormalities, including 2 that are specific to ALS motor neurons: (1) pathological changes related to the mislocalization of the TAR DNA-binding protein (TDP-43), including both the appearance of phosphorylated TDP-43-containing inclusions in the cytoplasm and the loss of TDP-43 from the nucleus; and (2) inefficient RNA editing at the Q/R site of GluA2, a subunit of the AMPA receptor. TDP-43-related pathological features are closely associated with ALS in most ALS patients and with significant behavioral and pathological changes in genetically engineered mice; therefore, abnormal TDP-43 processing is believed to play a role in the pathogenesis of ALS. The extent of GluA2 RNA editing decreases in the motor neurons of sporadic ALS patients in a disease-specific and motor neuron-selective manner. Importantly, this molecular abnormality is a direct cause of death of motor neurons in conditional knockout mice for adenosine deaminase acting on RNA 2 (ADAR2), the enzyme that specifically catalyzes RNA editing at the GluA2 Q/R site. Notably, these molecular abnormalities, i.e., TDP-43-related pathological features and inefficient GluA2 RNA editing, are found in approximately half of the motor neurons in sporadic ALS patients and both of them always occur in the same motor neurons. Because TDP-43-related pathological features and inefficient GluA2 RNA editing are highly disease specific in ALS motor neurons, investigation into the molecular link between these abnormalities is likely to provide new insights into ALS pathogenesis.